Biodesix Announces First Quarter 2022 Results and Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St futures drop as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- Oil gains over 3% as US-Iran peace talks in stalemate
- Stock action shows confidence in central banks: BofA’s Hartnett
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Biodesix Inc. (BDSX) Misses Q1 EPS by 7c
May 11, 2022 6:06 AM EDTBiodesix Inc. (NASDAQ: BDSX) reported Q1 EPS of ($0.50), $0.07 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $6.5 million versus the consensus estimate of $6.45 million.
GUIDANCE:
Biodesix Inc. sees FY2022 revenue of $37.5-39.5 million, versus the consensus of... More
